Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Q BioMed Inc. (QBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00750.0000 (0.00%)
At close: 03:24PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/3/2023
Current
8/31/20225/31/20222/28/202211/30/2021
Market Cap (intraday)
527.38k1.20M3.43M8.92M12.93M
Enterprise Value
9.42M10.11M12.71M17.71M20.05M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
111.11N/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
0.682.1711.2842.71127.26
Price/Book (mrq)
N/AN/AN/AN/AN/A
Enterprise Value/Revenue
25.00384.8474.54235.91191.08
Enterprise Value/EBITDA
-1.89-18.62-15.81-9.51-11.23

Trading Information

Stock Price History

Beta (5Y Monthly) 2.46
52-Week Change 3-98.26%
S&P500 52-Week Change 3-7.75%
52 Week High 30.4840
52 Week Low 30.0060
50-Day Moving Average 30.0122
200-Day Moving Average 30.0494

Share Statistics

Avg Vol (3 month) 31.48M
Avg Vol (10 day) 32.7M
Shares Outstanding 570.32M
Implied Shares Outstanding 6N/A
Float 865.79M
% Held by Insiders 18.07%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22499:1000
Last Split Date 3Aug 06, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 29, 2021
Most Recent Quarter (mrq)Aug 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,195.07%

Management Effectiveness

Return on Assets (ttm)-511.82%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)376.74k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-42.50%
Gross Profit (ttm)-51.25k
EBITDA -4.45M
Net Income Avi to Common (ttm)-7.88M
Diluted EPS (ttm)-0.3050
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.83k
Total Cash Per Share (mrq)0
Total Debt (mrq)3.77M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.02
Book Value Per Share (mrq)-0.22

Cash Flow Statement

Operating Cash Flow (ttm)-2.29M
Levered Free Cash Flow (ttm)39.74k
Advertisement
Advertisement